University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Red Monobenzone 20% in suitable emollient

Unlicensed special

Status: Red Morphine sulphate 5mg/5ml intrathecal injection

For West Midlands Rehab Unit only

Status: Green Morphine sulphate M/R capsules

Zomorph

Status: Green Morphine sulphate M/R sachets

MST continus

Status: Red Moviprep

For radiology use

Status: Amber Multivitamin supplement (Paravit-cF®)

CF specialist recommendation

Status: Red Mycophenolate

Specialist use only in neurological conditions

Status: Amber Mycophenolate mofetil

ESCA. For use in connective tissue diseases. For specialist initiation and dose stabilisation.

Status: Red Mycophenolate mofetil suspension

New post-transplant

Status: Amber Mycophenolate mofetil suspension

Post-transplant pre 2013

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top